← Open Payments lookup

ALISSA MACIAS: Open Payments

NPI 1952658445 · SAN MARCOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$922 in 38 payments from 12 companies in 2025. Trend: 2023 $374 · 2024 $765 · 2025 $922

Food & beverage: $922
CompanyPaymentsAmount
Gilead Sciences, Inc.12$220
Braeburn Inc.3$166
Madrigal Pharmaceuticals4$101
Lilly USA, LLC4$78
Novo Nordisk Inc3$75
ABBVIE INC.3$75
Xeris Pharmaceuticals, Inc.3$57
Edwards Lifesciences Corporation1$43
SCILEX PHARMACEUTICALS INC.2$40
GlaxoSmithKline, LLC.1$29

Products named: BRIXADI, REZDIFFRA, MOUNJARO, SAPIEN 3 Ultra RESILIA, ELYXYB - CELECOXIB, GVOKE HYPOPEN, UBRELVY, SHINGRIX.

Industry payments across CA — which companies pay providers there.